Phosphodiesterase type iii (pde iii) inhibitors or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/501 (2006.01) A61K 31/4174 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61K 31/50 (2006.01) A61P 9/04 (2006.01)

Patent

CA 2744505

The present invention relates to a phosphodiesterase type III (PDE III) inhibitor and/or Ca2+- sensitizing agent or a pharmaceutically acceptable derivative thereof for the treatment of a patient suffering from hypertrophic cardiomyopathy (HCM). According to another aspect the present invention relates to the use of a PDE III inhibitor and/or Ca2+-sensitizing agent for the preparation of a medicament for the treatment of a patient suffering from HCM.

La présente invention porte sur un inhibiteur de phosphodiestérase de type III (PDE III) et/ou un agent sensibilisateur au Ca2+ ou sur un dérivé pharmaceutiquement acceptable de ceux-ci pour le traitement d'un patient souffrant d'une cardiomyopathie hypertrophique (HCM). Sous un autre aspect, la présente invention porte sur l'utilisation d'un inhibiteur de PDE III et/ou un agent sensibilisateur au Ca2+ pour la préparation d'un médicament pour le traitement d'un patient souffrant d'une HCM.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phosphodiesterase type iii (pde iii) inhibitors or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphodiesterase type iii (pde iii) inhibitors or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphodiesterase type iii (pde iii) inhibitors or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1937978

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.